Report Detail

Request for Sample of this report

Machinery & Equipment Global PRRS Vaccines Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

  • RnM4594722
    • |
  • 12 June, 2024
    • |
  • Global
    • |
  • 132 Pages
    • |
  • GIR (Global Info Research)
    • |
  • Machinery & Equipment

According to our (Global Info Research) latest study, the global PRRS Vaccines market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
There are two types of PRRS vaccines that are commercially available. One is a modified-live virus (MLV) vaccine and the other is a killed virus (KV) vaccine. PRRS MLV vaccine is well recognized for its protective efficacy against PRRSV that are genetically homologous to the vaccine virus.
The Global Info Research report includes an overview of the development of the PRRS Vaccines industry chain, the market status of Government Tender (Live Vaccines, Killed Vaccines), Market Sales (Live Vaccines, Killed Vaccines), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of PRRS Vaccines.
Regionally, the report analyzes the PRRS Vaccines markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global PRRS Vaccines market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the PRRS Vaccines market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the PRRS Vaccines industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Live Vaccines, Killed Vaccines).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the PRRS Vaccines market.
Regional Analysis: The report involves examining the PRRS Vaccines market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the PRRS Vaccines market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to PRRS Vaccines:
Company Analysis: Report covers individual PRRS Vaccines manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards PRRS Vaccines This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Government Tender, Market Sales).
Technology Analysis: Report covers specific technologies relevant to PRRS Vaccines. It assesses the current state, advancements, and potential future developments in PRRS Vaccines areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the PRRS Vaccines market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
PRRS Vaccines market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Live Vaccines
Killed Vaccines
Market segment by Application
Government Tender
Market Sales
Major players covered
CAHIC
Merial
MSD Animal Health
Chopper Biology
Ceva
ChengDu Tecbond
Veterinary
Ringpu Biology
Qilu Animal
DHN
CAVAC
Komipharm
Agrovet
Bioveta
Jinyu Bio-Technology
Institutul Pasteur
MVP
Tecon
Zoetis
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe PRRS Vaccines product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of PRRS Vaccines, with price, sales, revenue and global market share of PRRS Vaccines from 2019 to 2024.
Chapter 3, the PRRS Vaccines competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the PRRS Vaccines breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and PRRS Vaccines market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of PRRS Vaccines.
Chapter 14 and 15, to describe PRRS Vaccines sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope of PRRS Vaccines
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global PRRS Vaccines Consumption Value by Type: 2019 Versus 2023 Versus 2030
    • 1.3.2 Live Vaccines
    • 1.3.3 Killed Vaccines
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global PRRS Vaccines Consumption Value by Application: 2019 Versus 2023 Versus 2030
    • 1.4.2 Government Tender
    • 1.4.3 Market Sales
  • 1.5 Global PRRS Vaccines Market Size & Forecast
    • 1.5.1 Global PRRS Vaccines Consumption Value (2019 & 2023 & 2030)
    • 1.5.2 Global PRRS Vaccines Sales Quantity (2019-2030)
    • 1.5.3 Global PRRS Vaccines Average Price (2019-2030)

2 Manufacturers Profiles

  • 2.1 CAHIC
    • 2.1.1 CAHIC Details
    • 2.1.2 CAHIC Major Business
    • 2.1.3 CAHIC PRRS Vaccines Product and Services
    • 2.1.4 CAHIC PRRS Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.1.5 CAHIC Recent Developments/Updates
  • 2.2 Merial
    • 2.2.1 Merial Details
    • 2.2.2 Merial Major Business
    • 2.2.3 Merial PRRS Vaccines Product and Services
    • 2.2.4 Merial PRRS Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.2.5 Merial Recent Developments/Updates
  • 2.3 MSD Animal Health
    • 2.3.1 MSD Animal Health Details
    • 2.3.2 MSD Animal Health Major Business
    • 2.3.3 MSD Animal Health PRRS Vaccines Product and Services
    • 2.3.4 MSD Animal Health PRRS Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.3.5 MSD Animal Health Recent Developments/Updates
  • 2.4 Chopper Biology
    • 2.4.1 Chopper Biology Details
    • 2.4.2 Chopper Biology Major Business
    • 2.4.3 Chopper Biology PRRS Vaccines Product and Services
    • 2.4.4 Chopper Biology PRRS Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.4.5 Chopper Biology Recent Developments/Updates
  • 2.5 Ceva
    • 2.5.1 Ceva Details
    • 2.5.2 Ceva Major Business
    • 2.5.3 Ceva PRRS Vaccines Product and Services
    • 2.5.4 Ceva PRRS Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.5.5 Ceva Recent Developments/Updates
  • 2.6 ChengDu Tecbond
    • 2.6.1 ChengDu Tecbond Details
    • 2.6.2 ChengDu Tecbond Major Business
    • 2.6.3 ChengDu Tecbond PRRS Vaccines Product and Services
    • 2.6.4 ChengDu Tecbond PRRS Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.6.5 ChengDu Tecbond Recent Developments/Updates
  • 2.7 Veterinary
    • 2.7.1 Veterinary Details
    • 2.7.2 Veterinary Major Business
    • 2.7.3 Veterinary PRRS Vaccines Product and Services
    • 2.7.4 Veterinary PRRS Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.7.5 Veterinary Recent Developments/Updates
  • 2.8 Ringpu Biology
    • 2.8.1 Ringpu Biology Details
    • 2.8.2 Ringpu Biology Major Business
    • 2.8.3 Ringpu Biology PRRS Vaccines Product and Services
    • 2.8.4 Ringpu Biology PRRS Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.8.5 Ringpu Biology Recent Developments/Updates
  • 2.9 Qilu Animal
    • 2.9.1 Qilu Animal Details
    • 2.9.2 Qilu Animal Major Business
    • 2.9.3 Qilu Animal PRRS Vaccines Product and Services
    • 2.9.4 Qilu Animal PRRS Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.9.5 Qilu Animal Recent Developments/Updates
  • 2.10 DHN
    • 2.10.1 DHN Details
    • 2.10.2 DHN Major Business
    • 2.10.3 DHN PRRS Vaccines Product and Services
    • 2.10.4 DHN PRRS Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.10.5 DHN Recent Developments/Updates
  • 2.11 CAVAC
    • 2.11.1 CAVAC Details
    • 2.11.2 CAVAC Major Business
    • 2.11.3 CAVAC PRRS Vaccines Product and Services
    • 2.11.4 CAVAC PRRS Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.11.5 CAVAC Recent Developments/Updates
  • 2.12 Komipharm
    • 2.12.1 Komipharm Details
    • 2.12.2 Komipharm Major Business
    • 2.12.3 Komipharm PRRS Vaccines Product and Services
    • 2.12.4 Komipharm PRRS Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.12.5 Komipharm Recent Developments/Updates
  • 2.13 Agrovet
    • 2.13.1 Agrovet Details
    • 2.13.2 Agrovet Major Business
    • 2.13.3 Agrovet PRRS Vaccines Product and Services
    • 2.13.4 Agrovet PRRS Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.13.5 Agrovet Recent Developments/Updates
  • 2.14 Bioveta
    • 2.14.1 Bioveta Details
    • 2.14.2 Bioveta Major Business
    • 2.14.3 Bioveta PRRS Vaccines Product and Services
    • 2.14.4 Bioveta PRRS Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.14.5 Bioveta Recent Developments/Updates
  • 2.15 Jinyu Bio-Technology
    • 2.15.1 Jinyu Bio-Technology Details
    • 2.15.2 Jinyu Bio-Technology Major Business
    • 2.15.3 Jinyu Bio-Technology PRRS Vaccines Product and Services
    • 2.15.4 Jinyu Bio-Technology PRRS Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.15.5 Jinyu Bio-Technology Recent Developments/Updates
  • 2.16 Institutul Pasteur
    • 2.16.1 Institutul Pasteur Details
    • 2.16.2 Institutul Pasteur Major Business
    • 2.16.3 Institutul Pasteur PRRS Vaccines Product and Services
    • 2.16.4 Institutul Pasteur PRRS Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.16.5 Institutul Pasteur Recent Developments/Updates
  • 2.17 MVP
    • 2.17.1 MVP Details
    • 2.17.2 MVP Major Business
    • 2.17.3 MVP PRRS Vaccines Product and Services
    • 2.17.4 MVP PRRS Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.17.5 MVP Recent Developments/Updates
  • 2.18 Tecon
    • 2.18.1 Tecon Details
    • 2.18.2 Tecon Major Business
    • 2.18.3 Tecon PRRS Vaccines Product and Services
    • 2.18.4 Tecon PRRS Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.18.5 Tecon Recent Developments/Updates
  • 2.19 Zoetis
    • 2.19.1 Zoetis Details
    • 2.19.2 Zoetis Major Business
    • 2.19.3 Zoetis PRRS Vaccines Product and Services
    • 2.19.4 Zoetis PRRS Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.19.5 Zoetis Recent Developments/Updates

3 Competitive Environment: PRRS Vaccines by Manufacturer

  • 3.1 Global PRRS Vaccines Sales Quantity by Manufacturer (2019-2024)
  • 3.2 Global PRRS Vaccines Revenue by Manufacturer (2019-2024)
  • 3.3 Global PRRS Vaccines Average Price by Manufacturer (2019-2024)
  • 3.4 Market Share Analysis (2023)
    • 3.4.1 Producer Shipments of PRRS Vaccines by Manufacturer Revenue ($MM) and Market Share (%): 2023
    • 3.4.2 Top 3 PRRS Vaccines Manufacturer Market Share in 2023
    • 3.4.2 Top 6 PRRS Vaccines Manufacturer Market Share in 2023
  • 3.5 PRRS Vaccines Market: Overall Company Footprint Analysis
    • 3.5.1 PRRS Vaccines Market: Region Footprint
    • 3.5.2 PRRS Vaccines Market: Company Product Type Footprint
    • 3.5.3 PRRS Vaccines Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global PRRS Vaccines Market Size by Region
    • 4.1.1 Global PRRS Vaccines Sales Quantity by Region (2019-2030)
    • 4.1.2 Global PRRS Vaccines Consumption Value by Region (2019-2030)
    • 4.1.3 Global PRRS Vaccines Average Price by Region (2019-2030)
  • 4.2 North America PRRS Vaccines Consumption Value (2019-2030)
  • 4.3 Europe PRRS Vaccines Consumption Value (2019-2030)
  • 4.4 Asia-Pacific PRRS Vaccines Consumption Value (2019-2030)
  • 4.5 South America PRRS Vaccines Consumption Value (2019-2030)
  • 4.6 Middle East and Africa PRRS Vaccines Consumption Value (2019-2030)

5 Market Segment by Type

  • 5.1 Global PRRS Vaccines Sales Quantity by Type (2019-2030)
  • 5.2 Global PRRS Vaccines Consumption Value by Type (2019-2030)
  • 5.3 Global PRRS Vaccines Average Price by Type (2019-2030)

6 Market Segment by Application

  • 6.1 Global PRRS Vaccines Sales Quantity by Application (2019-2030)
  • 6.2 Global PRRS Vaccines Consumption Value by Application (2019-2030)
  • 6.3 Global PRRS Vaccines Average Price by Application (2019-2030)

7 North America

  • 7.1 North America PRRS Vaccines Sales Quantity by Type (2019-2030)
  • 7.2 North America PRRS Vaccines Sales Quantity by Application (2019-2030)
  • 7.3 North America PRRS Vaccines Market Size by Country
    • 7.3.1 North America PRRS Vaccines Sales Quantity by Country (2019-2030)
    • 7.3.2 North America PRRS Vaccines Consumption Value by Country (2019-2030)
    • 7.3.3 United States Market Size and Forecast (2019-2030)
    • 7.3.4 Canada Market Size and Forecast (2019-2030)
    • 7.3.5 Mexico Market Size and Forecast (2019-2030)

8 Europe

  • 8.1 Europe PRRS Vaccines Sales Quantity by Type (2019-2030)
  • 8.2 Europe PRRS Vaccines Sales Quantity by Application (2019-2030)
  • 8.3 Europe PRRS Vaccines Market Size by Country
    • 8.3.1 Europe PRRS Vaccines Sales Quantity by Country (2019-2030)
    • 8.3.2 Europe PRRS Vaccines Consumption Value by Country (2019-2030)
    • 8.3.3 Germany Market Size and Forecast (2019-2030)
    • 8.3.4 France Market Size and Forecast (2019-2030)
    • 8.3.5 United Kingdom Market Size and Forecast (2019-2030)
    • 8.3.6 Russia Market Size and Forecast (2019-2030)
    • 8.3.7 Italy Market Size and Forecast (2019-2030)

9 Asia-Pacific

  • 9.1 Asia-Pacific PRRS Vaccines Sales Quantity by Type (2019-2030)
  • 9.2 Asia-Pacific PRRS Vaccines Sales Quantity by Application (2019-2030)
  • 9.3 Asia-Pacific PRRS Vaccines Market Size by Region
    • 9.3.1 Asia-Pacific PRRS Vaccines Sales Quantity by Region (2019-2030)
    • 9.3.2 Asia-Pacific PRRS Vaccines Consumption Value by Region (2019-2030)
    • 9.3.3 China Market Size and Forecast (2019-2030)
    • 9.3.4 Japan Market Size and Forecast (2019-2030)
    • 9.3.5 Korea Market Size and Forecast (2019-2030)
    • 9.3.6 India Market Size and Forecast (2019-2030)
    • 9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
    • 9.3.8 Australia Market Size and Forecast (2019-2030)

10 South America

  • 10.1 South America PRRS Vaccines Sales Quantity by Type (2019-2030)
  • 10.2 South America PRRS Vaccines Sales Quantity by Application (2019-2030)
  • 10.3 South America PRRS Vaccines Market Size by Country
    • 10.3.1 South America PRRS Vaccines Sales Quantity by Country (2019-2030)
    • 10.3.2 South America PRRS Vaccines Consumption Value by Country (2019-2030)
    • 10.3.3 Brazil Market Size and Forecast (2019-2030)
    • 10.3.4 Argentina Market Size and Forecast (2019-2030)

11 Middle East & Africa

  • 11.1 Middle East & Africa PRRS Vaccines Sales Quantity by Type (2019-2030)
  • 11.2 Middle East & Africa PRRS Vaccines Sales Quantity by Application (2019-2030)
  • 11.3 Middle East & Africa PRRS Vaccines Market Size by Country
    • 11.3.1 Middle East & Africa PRRS Vaccines Sales Quantity by Country (2019-2030)
    • 11.3.2 Middle East & Africa PRRS Vaccines Consumption Value by Country (2019-2030)
    • 11.3.3 Turkey Market Size and Forecast (2019-2030)
    • 11.3.4 Egypt Market Size and Forecast (2019-2030)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
    • 11.3.6 South Africa Market Size and Forecast (2019-2030)

12 Market Dynamics

  • 12.1 PRRS Vaccines Market Drivers
  • 12.2 PRRS Vaccines Market Restraints
  • 12.3 PRRS Vaccines Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of PRRS Vaccines and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of PRRS Vaccines
  • 13.3 PRRS Vaccines Production Process
  • 13.4 PRRS Vaccines Industrial Chain

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 PRRS Vaccines Typical Distributors
  • 14.3 PRRS Vaccines Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on PRRS Vaccines. Industry analysis & Market Report on PRRS Vaccines is a syndicated market report, published as Global PRRS Vaccines Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030. It is complete Research Study and Industry Analysis of PRRS Vaccines market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,648.28
    		3,972.42
    		5,296.56
    		3,138.96
    		4,708.44
    		6,277.92
    		496,282.80
    		744,424.20
    		992,565.60
    		292,250.40
    		438,375.60
    		584,500.80
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo